In vivo protection of experimentally envenomed mice.
A, mice were injected by the subcutaneous route with doses greater than the LD50 of freshly calibrated venom (2 LD50, 3 LD50, or 4 LD50). B, mice were treated after the s.c. injection of 3 LD50 by intraperitoneal injection with PBS-BSA 0.1%, Db4C1op, Db9C2, mixture Db4C1/Db9C2, or mixture Db4C1/Db9C2 injected 5 min after the venom.